Maltose Falsely Elevated Diabetics' Readings: FDA
The U.S. Food and Drug Administration said in a final report issued last week it had identified seven adverse events, including two deaths, in diabetic patients who received immune globulin products...To view the full article, register now.
Already a subscriber? Click here to view full article